Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease

Nature Neuroscience
Usman A KhanScott A Small

Abstract

The entorhinal cortex has been implicated in the early stages of Alzheimer's disease, which is characterized by changes in the tau protein and in the cleaved fragments of the amyloid precursor protein (APP). We used a high-resolution functional magnetic resonance imaging (fMRI) variant that can map metabolic defects in patients and mouse models to address basic questions about entorhinal cortex pathophysiology. The entorhinal cortex is divided into functionally distinct regions, the medial entorhinal cortex (MEC) and the lateral entorhinal cortex (LEC), and we exploited the high-resolution capabilities of the fMRI variant to ask whether either of them was affected in patients with preclinical Alzheimer's disease. Next, we imaged three mouse models of disease to clarify how tau and APP relate to entorhinal cortex dysfunction and to determine whether the entorhinal cortex can act as a source of dysfunction observed in other cortical areas. We found that the LEC was affected in preclinical disease, that LEC dysfunction could spread to the parietal cortex during preclinical disease and that APP expression potentiated tau toxicity in driving LEC dysfunction, thereby helping to explain regional vulnerability in the disease.

References

Dec 15, 1992·The Journal of Comparative Neurology·R F Hevner, M T Wong-Riley
Feb 1, 1992·Neurology·R C PetersenE G Tangalos
Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Jan 1, 1983·Annual Review of Neuroscience·M E Raichle
Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Dec 22, 1994·The Journal of Comparative Neurology·W A Suzuki, D G Amaral
Feb 19, 1996·The Journal of Comparative Neurology·A Solodkin, G W Van Hoesen
Jan 7, 1998·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·M S Albert
Feb 25, 1999·Journal of Magnetic Resonance Imaging : JMRI·W LinR P Paczynski
Mar 29, 2000·JAMA : the Journal of the American Medical Association·J NäslundJ D Buxbaum
Oct 26, 2002·Science·Dennis J Selkoe
Mar 3, 2004·Annals of Neurology·William E KlunkBengt Långström
May 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Scott A SmallCarol A Barnes
May 27, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Joanna L JankowskyAlena V Savonenko
Mar 23, 2006·NMR in Biomedicine·Herman MorenoScott Small
Oct 10, 2007·Archives of Neurology·Herman MorenoScott A Small
Feb 27, 2008·Annals of Neurology·Jennifer J ManlyRichard Mayeux
Sep 5, 2008·Neural Plasticity·Cathrin B CantoMenno P Witter
Sep 25, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rosanna K OlsenAnthony D Wagner
Apr 10, 2010·IEEE Transactions on Medical Imaging·Nicholas J TustisonJames C Gee
Jul 20, 2010·NeuroImage·Martin ReuterBruce Fischl
Sep 9, 2010·Hippocampus·Adam M BrickmanScott A Small
Jun 28, 2011·NeuroImage·Kay RichardsDavid C Reutens
Dec 24, 2011·Human Molecular Genetics·Tamar SapirOrly Reiner
Feb 9, 2012·PloS One·Li LiuKaren Duff
Mar 1, 2012·Neuron·Alix de CalignonBradley T Hyman

❮ Previous
Next ❯

Citations

Oct 27, 2014·Nature Neuroscience·Adam M BrickmanScott A Small
Aug 6, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deng-Feng ZhangYong-Gang Yao
Dec 5, 2015·Frontiers in Human Neuroscience·Heidrun SchultzJan Peters
Jun 9, 2015·ELife·Anne MaassEmrah Düzel
Jun 9, 2015·ELife·Tobias Navarro SchröderChristian F Doeller
Feb 12, 2015·Nature Reviews. Neuroscience·Scott A Small, Gregory A Petsko
Jun 7, 2014·Frontiers in Neuroanatomy·Maria Llorens-MartínJavier DeFelipe
Dec 11, 2014·Acta Neuropathologica·Rebecca M NisbetJürgen Götz
May 21, 2016·Frontiers in Physiology·Anna ChiariniIlaria Dal Prà
Oct 12, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Adam M BrickmanFlorence Portet
Jun 11, 2016·NeuroImage·Enrico KadenDaniel C Alexander
Nov 12, 2016·Frontiers in Systems Neuroscience·Alexandra S KleinPrateep Beed
Sep 23, 2014·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Mohamady El-GabyOle Paulsen
Apr 3, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Miranka WirthAgnes Flöel
Mar 5, 2017·NeuroImage·Yasser Iturria-MedinaUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 14, 2016·NeuroImage. Clinical·Zhuang SongDenise C Park
Feb 27, 2017·Brain Imaging and Behavior·Xiao LuoUNKNOWN Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Jun 21, 2017·Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition·Marta Matos GonçalvesMário R Simões
Jan 18, 2017·Evolution, Medicine, and Public Health·Randolph M NesseCharles L Nunn
Feb 8, 2018·Human Gene Therapy. Clinical Development·Jonathan B RosenbergRonald G Crystal
Apr 18, 2018·Journal of Alzheimer's Disease : JAD·Bardia NouriziabariKaori Takehara-Nishiuchi
Nov 11, 2017·Journal of Alzheimer's Disease : JAD·Javier Gustavo Villamil-OrtizGloria Patricia Cardona-Gómez
Aug 12, 2017·Assessment·Christiane HaleAdam M Brickman
May 10, 2018·Hippocampus·S C BarnettL C Parr-Brownlie
Jul 15, 2015·Histochemistry and Cell Biology·Amanda J BrockH Anne Pereira
Dec 23, 2015·Hippocampus·Zachariah M ReaghMichael A Yassa
Mar 1, 2018·Molecular Neurobiology·Seong Gak JeonMinho Moon
Sep 28, 2017·Reviews in the Neurosciences·Ahmed A MoustafaMichael Hornberger
Nov 5, 2016·Nature Communications·Taylor W SchmitzUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 31, 2018·Nature Medicine·Jorge SepulcreKeith A Johnson
Jan 27, 2018·Nature Neuroscience·Stephanie L Leal, Michael A Yassa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.